MetaADEDB 2.0 @ LMMD
Synjardy
(YBRWIMHXUHRVDV-ZBYKXHQASA-N)
Structure
SMILES
CN(C(=N)N=C(N)N)C.CO[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(cc2)O[C@@H]2COCC2)Cl)[C@@H]([C@H]([C@@H]1O)O)O.Cl
Molecular Formula:
C27H39Cl2N5O7
Molecular Weight:
616.534
Log P:
3.2835
Hydrogen Bond Acceptor:
12
Hydrogen Bond Donor:
7
TPSA:
189.1
CAS Number(s):
N/A
Synonym(s)
1.
Synjardy
External Link(s)
PubChem Compound85364160
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Diabetic KetoacidosisFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
2KetoacidosisFAERS: 20US FAERS
3Weight decreasedFAERS: 11US FAERS
4NauseaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
5VomitingFAERS: 8US FAERS
6Blood glucose increasedFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Euglycaemic diabetic ketoacidosisFAERS: 7
Canada Vigilance: 6
Canada Vigilance
US FAERS
8Acute kidney injuryFAERS: 6US FAERS
9DizzinessFAERS: 6US FAERS
10AstheniaFAERS: 5US FAERS
11ConstipationFAERS: 5US FAERS
12Urinary tract infectionFAERS: 5US FAERS
13ArthralgiaFAERS: 4US FAERS
14Drug ineffectiveFAERS: 4US FAERS
15FatigueFAERS: 4US FAERS
16PruritusFAERS: 4US FAERS
17Abdominal PainFAERS: 3US FAERS
18FlatulenceFAERS: 3US FAERS
19HeadacheFAERS: 3US FAERS
20AlopeciaFAERS: 2US FAERS
21AmputationFAERS: 2US FAERS
22Blood glucose abnormalFAERS: 2US FAERS
23Blood glucose decreasedFAERS: 2US FAERS
24CholangitisFAERS: 2US FAERS
25DehydrationFAERS: 2US FAERS
26Diabetes mellitus inadequate controlFAERS: 2US FAERS
27HypersensitivityFAERS: 2US FAERS
28HypotensionFAERS: 2US FAERS
29KetonuriaFAERS: 2US FAERS
30Metabolic acidosisFAERS: 2US FAERS
31Myocardial InfarctionFAERS: 2US FAERS
32Product residue presentFAERS: 2US FAERS
33UrticariaFAERS: 2US FAERS
34Abdominal discomfortFAERS: 1US FAERS
35AbscessFAERS: 1US FAERS
36Accidental overdoseFAERS: 1US FAERS
37AcidosisFAERS: 1US FAERS
38Alanine Aminotransferase IncreasedFAERS: 1US FAERS
39AlbuminuriaFAERS: 1US FAERS
40Autonomic neuropathyFAERS: 1US FAERS
41Back PainFAERS: 1US FAERS
42Blood alkaline phosphatase increasedFAERS: 1US FAERS
43Blood cholesterol increasedFAERS: 1US FAERS
44Blood ketone bodyFAERS: 1US FAERS
45Blood pH abnormalFAERS: 1US FAERS
46Bowel movement irregularityFAERS: 1US FAERS
47BronchitisFAERS: 1US FAERS
48BronchopneumopathyFAERS: 1US FAERS
49Burning sensationFAERS: 1US FAERS
50CachexiaFAERS: 1US FAERS
51Chest PainFAERS: 1US FAERS
52Craniofacial fractureFAERS: 1US FAERS
53Decreased insulin requirementFAERS: 1US FAERS
54Dental cariesFAERS: 1US FAERS
55Diastolic dysfunctionFAERS: 1US FAERS
56Disease complicationFAERS: 1US FAERS
57Drug dispensing errorFAERS: 1US FAERS
58Drug prescribing errorFAERS: 1US FAERS
59Dry gangreneFAERS: 1US FAERS
60DyspepsiaFAERS: 1US FAERS
61Electrocardiogram QT interval abnormalFAERS: 1US FAERS
62Electrolyte imbalanceFAERS: 1US FAERS
63Erectile dysfunctionFAERS: 1US FAERS
64Escherichia urinary tract infectionFAERS: 1US FAERS
65Euphoric moodFAERS: 1US FAERS
66Extremity necrosisFAERS: 1US FAERS
67FasciitisFAERS: 1US FAERS
68Feeling abnormalFAERS: 1US FAERS
69Flank PainFAERS: 1US FAERS
70General physical health deteriorationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
71Head discomfortFAERS: 1US FAERS
72HepatitisFAERS: 1US FAERS
73HerniaFAERS: 1US FAERS
74HypophagiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
75Inappropriate affectFAERS: 1US FAERS
76Incorrect dose administeredFAERS: 1US FAERS
77Incorrect product dosage form administeredFAERS: 1US FAERS
78InfectionFAERS: 1US FAERS
79Inflammatory marker increasedFAERS: 1US FAERS
80Intraocular pressure testFAERS: 1US FAERS
81Joint swellingFAERS: 1US FAERS
82Leriche SyndromeFAERS: 1US FAERS
83LethargyFAERS: 1US FAERS
84Lip swellingFAERS: 1US FAERS
85MalaiseFAERS: 1US FAERS
86Muscle FatigueFAERS: 1US FAERS
87Mycosis FungoidesFAERS: 1US FAERS
88MyoclonusFAERS: 1US FAERS
89NasopharyngitisFAERS: 1US FAERS
90NervousnessFAERS: 1US FAERS
91Oropharyngeal painFAERS: 1US FAERS
92OsteomyelitisFAERS: 1US FAERS
93PainFAERS: 1US FAERS
94PalpitationsFAERS: 1US FAERS
95PhotophobiaFAERS: 1US FAERS
96PneumoniaFAERS: 1US FAERS
97Polymyalgia RheumaticaFAERS: 1US FAERS
98Poor peripheral circulationFAERS: 1US FAERS
99Product dispensing errorFAERS: 1US FAERS
100Product quality issueFAERS: 1US FAERS
101Product substitution issueFAERS: 1US FAERS
102Renal painFAERS: 1US FAERS
103SepsisFAERS: 1US FAERS
104Sinus TachycardiaFAERS: 1US FAERS
105SomnolenceFAERS: 1US FAERS
106TachycardiaFAERS: 1US FAERS
107ThirstFAERS: 1US FAERS
108Thyroid hormones increasedFAERS: 1US FAERS
109TinnitusFAERS: 1US FAERS
110Urine flow decreasedFAERS: 1US FAERS
111Urine ketone bodyFAERS: 1US FAERS
112Urine ketone body presentFAERS: 1US FAERS
113Ventricular hypertrophyFAERS: 1US FAERS
114Visual ImpairmentFAERS: 1US FAERS
115Vulvovaginal mycotic infectionFAERS: 1US FAERS
116Vulvovaginal pruritusFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.